Assessment of FIBROSpect II to Detect Hepatic Fibrosis in Chronic Hepatitis C Patients

American Journal of Medicine

Volumn 120, Issue 3, 2007, Pages

  Zaman, Atif ^a   Rosen, Hugo R ^a   Ingram, Ken ^a   Corless, Christopher L ^a   Oh, Esther ^b   Smith, Katie ^b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b Prometheus Laboratories   (United States)

Author keywords

Hepatic fibrosis; Hepatitis C

Indexed keywords

ALPHA 2 MACROGLOBULIN; HYALURONIC ACID; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; ARTICLE; CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; CLINICAL ASSESSMENT; CLINICAL LABORATORY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS C; HISTOLOGY; HUMAN; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NEPHELOMETRY; PRIORITY JOURNAL; SERUM; VIRUS HEPATITIS;

ADULT; ALGORITHMS; ALPHA-MACROGLOBULINS; AMBULATORY CARE; BIOLOGICAL MARKERS; BIOPSY, NEEDLE; CONFIDENCE INTERVALS; DISEASE PROGRESSION; FEMALE; HEPATITIS C, CHRONIC; HUMANS; HYALURONIC ACID; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROBABILITY; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 33847354646     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2006.06.044     Document Type: Article

References (13)

1. Rockey D.C. Antifibrotic therapy in chronic liver disease. Clin Gastroenterol Hepatol 3 2 (2005) 95-107
2. Schuppan D., Ruehl M., Somasundaram R., et al. Matrix as a modulator of hepatic fibrogenesis. Semin Liver Dis 21 (2001) 351-372
3. Eng F.J., and Friedman S.L. Fibrogenesis I. New insights into hepatic stellate cell activation: the simple becomes complex. Am J Physiol 279 (2000) G7-G11
4. Knodell R.G., Ishak K.G., Black W.C., et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1 5 (1981) 431-435
5. Ishak K., Baptista A., Bianchi L., et al. Histological grading and staging of chronic hepatitis. J Hepatol 22 6 (1995) 696-699
6. Bedossa P., Poynard T., and The METAVIR Cooperative Study Group. An algorithm for the grading of activity in chroinic hepatitis C. Hepatology 24 2 (1996) 289-293
7. Bravo A., Sheth S., and Chopra S. Liver biopsy. N Engl J Med 344 7 (2001) 495-500
8. Colombo M., Del Ninno E., de Franchis R., et al. Ultrasound assisted percutaneous liver biopsy: superiority of the Trucut over the Menghini needle for the diagnosis of cirrhosis. Gastroenterology 95 (1988) 487-489
9. Poniachik J., Bernstein D.E., Reddy K.R., et al. The role of laparoscopy in the diagnosis of cirrhosis. Gastrointest Endosc 43 (1996) 568-571
10. Patel K., Gordon S.C., Jacobson I., et al. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. J Hepatol 41 (2004) 935-942
11. Forns X., Ampurdanes S., Llovet J.M., et al. Identification of chronic hepatitis C without fibrosis by a simple predictive test. Hepatology 36 (2002) 986-992
12. Wai C.T., Greenson J.K., Fontana R.J., et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C. Hepatology 38 (2003) 518-526
13. Imbert-Bismut F., Ratziu V., Pieroni L., et al. Biochemical markers of liver fibrosis: a prospective study. Lancet 357 (2001) 1069-1075